|
|
|
|
LEADER |
00000nam a22000005i 4500 |
001 |
978-3-319-17362-7 |
003 |
DE-He213 |
005 |
20220116050302.0 |
007 |
cr nn 008mamaa |
008 |
150716s2015 sz | s |||| 0|eng d |
020 |
|
|
|a 9783319173627
|9 978-3-319-17362-7
|
024 |
7 |
|
|a 10.1007/978-3-319-17362-7
|2 doi
|
050 |
|
4 |
|a RC346-429.2
|
072 |
|
7 |
|a MJN
|2 bicssc
|
072 |
|
7 |
|a MED056000
|2 bisacsh
|
072 |
|
7 |
|a MKJ
|2 thema
|
082 |
0 |
4 |
|a 616.8
|2 23
|
245 |
1 |
0 |
|a Muscular Dystrophy
|h [electronic resource] :
|b A Concise Guide /
|c edited by Raymond A. Huml.
|
250 |
|
|
|a 1st ed. 2015.
|
264 |
|
1 |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2015.
|
300 |
|
|
|a XXIV, 191 p. 43 illus., 30 illus. in color.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
505 |
0 |
|
|a 1. Introduction to Muscular Dystrophy -- 2.Muscular Dystrophy: Historical Background and Types -- 3.FSHD: The Most Common Type of MD? -- 4.Duchenne and Becker Muscular Dystrophies: Underlying Genetic and Molecular Mechanisms -- 5.An Overview of the Muscular Dystrophies: Underlying Genetic and Molecular Mechanisms -- 6.Transition from Childhood to Adult in Patients with Muscular Dystrophy -- 7.Overview of Current Treatments for Muscular Dystrophy -- 8.Physical Therapy and Orthotic Devices for Patients with Muscular Dystrophy -- 9.Orthopedic Care of Children with Muscular Dystrophy -- 10.Global Regulatory Landscape -- 11.Key Challenges to the Approval of Products to Treat Patients with Muscular Dystrophy -- 12.Pharmaceutical Products and Non-Pharmaceutical Interventions as Potential Treatments for Patients with Muscular Dystrophy -- 13.US Patient Advocacy Groups -- 14.Global and National Patient Registries -- 15.Summary -- Index.
|
520 |
|
|
|a This practical and concise guide offers an overview of muscular dystrophy's (MD) complicated features, treatment options and general resources. New treatments and a greater understanding of proteins and structures associated with MD are discussed along with long-term patient care. Also included are clinical and developmental challenges within the current regulatory landscape and recent scientific and clinical advances. Muscular Dystrophy: A Concise Guide offers clinicians, researchers, pharmaceutical executives and patient advocacy groups an easy-to-read reference that provides the necessary perspectives of the care giver and patient.
|
650 |
|
0 |
|a Neurology .
|
650 |
|
0 |
|a Therapeutics.
|
650 |
|
0 |
|a Medical sciences.
|
650 |
1 |
4 |
|a Neurology.
|
650 |
2 |
4 |
|a Therapeutics.
|
650 |
2 |
4 |
|a Health Sciences.
|
700 |
1 |
|
|a Huml, Raymond A.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer Nature eBook
|
776 |
0 |
8 |
|i Printed edition:
|z 9783319173610
|
776 |
0 |
8 |
|i Printed edition:
|z 9783319173634
|
856 |
4 |
0 |
|u https://doi.uam.elogim.com/10.1007/978-3-319-17362-7
|z Texto Completo
|
912 |
|
|
|a ZDB-2-SME
|
912 |
|
|
|a ZDB-2-SXM
|
950 |
|
|
|a Medicine (SpringerNature-11650)
|
950 |
|
|
|a Medicine (R0) (SpringerNature-43714)
|